Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women

Cancer Causes and Control

Volumn 20, Issue 7, 2009, Pages 1055-1060

  Ha, Mina ^a   Sung, Joohon ^b,c   Song, Yun Mi ^d  

^a Dankook University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c National Cancer Center   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Body mass index; Breast neoplasms; Cholesterol; Koreans; Postmenopause

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SOUTH KOREA;

ADULT; BODY MASS INDEX; BREAST NEOPLASMS; CHOLESTEROL; FEMALE; GONADAL STEROID HORMONES; HUMANS; KOREA; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS;

EID: 68449084057     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9301-7     Document Type: Article

References (29)

1. AH Eliassen SA Missmer SS Tworoger 2006 Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women J Natl Cancer Inst 98 1406 1415
2. SA Missmer AH Eliassen RL Barbieri SE Hankinson 2004 Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women J Natl Cancer Inst 96 1856 1865
3. RA Hiatt GD Friedman RD Bawol HK Ury 1982 Breast cancer and serum cholesterol J Natl Cancer Inst 68 885 889
4. AP Hoyer G Engholm 1992 Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women Cancer Causes Control 3 403 408 10.1007/BF00051352
5. AH Eliassen GA Colditz B Rosner WC Willett SE Hankinson 2005 Serum lipids, lipid-lowering drugs, and the risk of breast cancer Arch Intern Med 165 2264 2271 10.1001/archinte.165.19.2264 (Pubitemid 41549923)
6. M Gaard S Tretli P Urdal 1994 Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women Cancer Causes Control 5 501 509 10.1007/BF01831377 (Pubitemid 24335712)
7. JA Kaye CR Meier AM Walker H Jick 2002 Statin use, hyperlipidaemia, and the risk of breast cancer Br J Cancer 86 1436 1439 10.1038/sj.bjc.6600267 (Pubitemid 34548066)
8. LJ Vatten OP Foss 1990 Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women Cancer Res 50 2341 2346
9. SA Tornberg LE Holm JM Carstensen 1988 Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure Acta Oncol 27 31 37 10.3109/02841868809090315
10. YH Li Y Li CE Davis 2002 Serum cholesterol changes from 1983-1984 to 1993-1994 in the People's Republic of China Nutr Metab Cardiovasc Dis 12 118 126
11. A Sekikawa LH Kuller H Ueshima 1999 Coronary heart disease mortality trends in men in the post World War II birth cohorts aged 35-44 in Japan, South Korea and Taiwan compared with the United States Int J Epidemiol 28 1044 1049 10.1093/ije/28.6.1044
12. A Okayama H Ueshima MG Marmot M Nakamura Y Kita M Yamakawa 1993 Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan 1980-1989 Int J Epidemiol 22 1038 1047 10.1093/ije/22.6.1038
13. S Tominaga T Kuroishi 1999 Epidemiology and prevention of breast cancer in the 21st century Breast Cancer 6 283 288 10.1007/BF02966440
14. KY Yoo Y Kim SK Park D Kang 2006 Lifestyle, genetic susceptibility and future trends of breast cancer in Korea Asian Pac J Cancer Prev 7 679 682
15. A Seow SW Duffy MA McGee J Lee HP Lee 1996 Breast cancer in Singapore: trends in incidence 1968-1992 Int J Epidemiol 25 40 45 10.1093/ije/25.1.40 (Pubitemid 26060268)
16. MS Brown PT Kovanen JL Goldstein 1981 Regulation of plasma cholesterol by lipoprotein receptors Science 212 628 635 10.1126/science.6261329
17. PT Kovanen 1987 Regulation of plasma cholesterol by hepatic low-density lipoprotein receptors Am Heart J 113 464 469 10.1016/0002-8703(87)90615-6 (Pubitemid 17026624)
18. CM Friedenreich 2001 Review of anthropometric factors and breast cancer risk Eur J Cancer Prev 10 15 32 10.1097/00008469-200102000-00003 (Pubitemid 32200199)
19. BS Hulka PG Moorman 2001 Breast cancer: hormones and other risk factors Maturitas 38 103 113 10.1016/S0378-5122(00)00196-1 (Pubitemid 32304388)
20. YJ Park BS Koo HC Kang SH Chun JW Yoon 2001 The menopausal age and climacteric symptoms, and the related factors of Korean women Korean J Women Health Nurs 7 473 485
21. YM Song J Sung JS Kim 2000 Which cholesterol level is related to the lowest mortality in a population with low mean cholesterol level: a 6.4-year follow-up study of 482,472 Korean men Am J Epidemiol 151 739 747
22. National Cancer Center (2007) Number of hospitals participating in Korea Central Cancer Registry
23. RB Wallace C Rost LF Burmeister PR Pomrehn 1982 Cancer incidence in humans: relationship to plasma lipids and relative weight J Natl Cancer Inst 68 915 918
24. P Beck DK Wysowski W Downey D Butler-Jones 2003 Statin use and the risk of breast cancer J Clin Epidemiol 56 280 285 10.1016/S0895-4356(02)00614-5 (Pubitemid 36513491)
25. S Bonovas K Filioussi N Tsavaris NM Sitaras 2005 Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies J Clin Oncol 23 8606 8612 10.1200/JCO.2005.02.7045 (Pubitemid 46211502)
26. DM Boudreau O Yu DL Miglioretti DS Buist SR Heckbert JR Daling 2007 Statin use and breast cancer risk in a large population-based setting Cancer Epidemiol Biomarkers Prev 16 416 421 10.1158/1055-9965.EPI-06-0737 (Pubitemid 46548643)
27. G Pocobelli PA Newcomb A Trentham-Dietz L Titus-Ernstoff JM Hampton KM Egan 2008 Statin use and risk of breast cancer Cancer 112 27 33 10.1002/cncr.23129
28. M Ferraroni M Gerber A Decarli 1993 HDL-cholesterol and breast cancer: a joint study in northern Italy and southern France Int J Epidemiol 22 772 780 10.1093/ije/22.5.772
29. AS Furberg MB Veierod T Wilsgaard L Bernstein I Thune 2004 Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk J Natl Cancer Inst 96 1152 1160